Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $28.71 $35.40 Friday, 10th May 2024 AGIO stock ended at $33.00. This is 0.243% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 1.97% from a day low at $32.45 to a day high of $33.09.
90 days $24.69 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Jun 01, 2016 $57.34 $57.34 $57.34 $57.34 832 982
May 31, 2016 $55.95 $55.95 $55.95 $55.95 727 095
May 27, 2016 $53.34 $53.34 $53.34 $53.34 333 861
May 26, 2016 $52.90 $52.90 $52.90 $52.90 660 901
May 25, 2016 $52.63 $52.63 $52.63 $52.63 1 062 322
May 24, 2016 $48.34 $48.34 $48.34 $48.34 869 340
May 23, 2016 $48.58 $48.58 $48.58 $48.58 764 611
May 20, 2016 $45.44 $45.44 $45.44 $45.44 926 532
May 19, 2016 $45.30 $45.30 $45.30 $45.30 1 197 769
May 18, 2016 $50.51 $50.51 $50.51 $50.51 796 889
May 17, 2016 $51.27 $51.27 $51.27 $51.27 807 148
May 16, 2016 $50.57 $50.57 $50.57 $50.57 728 935
May 13, 2016 $46.82 $46.82 $46.82 $46.82 794 610
May 12, 2016 $44.85 $44.85 $44.85 $44.85 747 648
May 11, 2016 $45.05 $45.05 $45.05 $45.05 642 982
May 10, 2016 $47.41 $47.41 $47.41 $47.41 491 413
May 09, 2016 $47.67 $47.67 $47.67 $47.67 579 148
May 06, 2016 $43.58 $43.58 $43.58 $43.58 663 287
May 05, 2016 $43.15 $43.15 $43.15 $43.15 678 304
May 04, 2016 $44.16 $44.16 $44.16 $44.16 706 117
May 03, 2016 $46.52 $46.52 $46.52 $46.52 456 345
May 02, 2016 $49.74 $49.74 $49.74 $49.74 555 206
Apr 29, 2016 $48.95 $48.95 $48.95 $48.95 542 105
Apr 28, 2016 $50.53 $50.53 $50.53 $50.53 408 185
Apr 27, 2016 $50.91 $50.91 $50.91 $50.91 465 872
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT